avrg: A549 cells infected with RSV Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TLX1
|
ENSG00000107807.8 | TLX1 |
NFIC
|
ENSG00000141905.13 | NFIC |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NFIC | hg19_v2_chr19_+_3359561_3359681 | -0.75 | 2.5e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_-_64764435 | 4.46 |
ENST00000534177.1 ENST00000301887.4 |
BATF2 |
basic leucine zipper transcription factor, ATF-like 2 |
chr15_+_90735145 | 2.83 |
ENST00000559792.1 |
SEMA4B |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
chr1_+_79086088 | 2.61 |
ENST00000370751.5 ENST00000342282.3 |
IFI44L |
interferon-induced protein 44-like |
chr17_+_74372662 | 2.51 |
ENST00000591651.1 ENST00000545180.1 |
SPHK1 |
sphingosine kinase 1 |
chr11_-_71751715 | 1.60 |
ENST00000535947.1 |
NUMA1 |
nuclear mitotic apparatus protein 1 |
chr17_+_7344057 | 1.58 |
ENST00000575398.1 ENST00000575082.1 |
FGF11 |
fibroblast growth factor 11 |
chr7_+_22766766 | 1.49 |
ENST00000426291.1 ENST00000401651.1 ENST00000258743.5 ENST00000420258.2 ENST00000407492.1 ENST00000401630.3 ENST00000406575.1 |
IL6 |
interleukin 6 (interferon, beta 2) |
chr17_+_19314432 | 1.43 |
ENST00000575165.2 |
RNF112 |
ring finger protein 112 |
chr1_-_200992827 | 1.43 |
ENST00000332129.2 ENST00000422435.2 |
KIF21B |
kinesin family member 21B |
chr21_+_33784670 | 1.29 |
ENST00000300255.2 |
EVA1C |
eva-1 homolog C (C. elegans) |
chr19_+_10397648 | 1.24 |
ENST00000340992.4 ENST00000393717.2 |
ICAM4 |
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) |
chr1_-_153363452 | 1.23 |
ENST00000368732.1 ENST00000368733.3 |
S100A8 |
S100 calcium binding protein A8 |
chr8_-_42065075 | 1.22 |
ENST00000429089.2 ENST00000519510.1 ENST00000429710.2 ENST00000524009.1 |
PLAT |
plasminogen activator, tissue |
chr19_+_10397621 | 1.18 |
ENST00000380770.3 |
ICAM4 |
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) |
chr5_-_176923803 | 1.17 |
ENST00000506161.1 |
PDLIM7 |
PDZ and LIM domain 7 (enigma) |
chr1_+_79115503 | 1.16 |
ENST00000370747.4 ENST00000438486.1 ENST00000545124.1 |
IFI44 |
interferon-induced protein 44 |
chr22_-_39640756 | 1.16 |
ENST00000331163.6 |
PDGFB |
platelet-derived growth factor beta polypeptide |
chr11_-_65149422 | 1.15 |
ENST00000526432.1 ENST00000527174.1 |
SLC25A45 |
solute carrier family 25, member 45 |
chr6_-_43595039 | 1.15 |
ENST00000307114.7 |
GTPBP2 |
GTP binding protein 2 |
chr12_-_54813229 | 1.14 |
ENST00000293379.4 |
ITGA5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
chr18_+_21529811 | 1.13 |
ENST00000588004.1 |
LAMA3 |
laminin, alpha 3 |
chr8_-_42065187 | 1.13 |
ENST00000270189.6 ENST00000352041.3 ENST00000220809.4 |
PLAT |
plasminogen activator, tissue |
chr7_-_75241096 | 1.11 |
ENST00000420909.1 |
HIP1 |
huntingtin interacting protein 1 |
chr21_+_33784957 | 1.07 |
ENST00000401402.3 ENST00000382699.3 |
EVA1C |
eva-1 homolog C (C. elegans) |
chr19_+_677885 | 1.03 |
ENST00000591552.2 |
FSTL3 |
follistatin-like 3 (secreted glycoprotein) |
chr5_-_176923846 | 1.02 |
ENST00000506537.1 |
PDLIM7 |
PDZ and LIM domain 7 (enigma) |
chr22_+_46449674 | 1.00 |
ENST00000381051.2 |
FLJ27365 |
hsa-mir-4763 |
chr7_+_143079000 | 1.00 |
ENST00000392910.2 |
ZYX |
zyxin |
chr15_+_89182178 | 0.96 |
ENST00000559876.1 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
chr1_+_113217345 | 0.95 |
ENST00000357443.2 |
MOV10 |
Mov10, Moloney leukemia virus 10, homolog (mouse) |
chr7_+_143078652 | 0.95 |
ENST00000354434.4 ENST00000449423.2 |
ZYX |
zyxin |
chr11_+_18417948 | 0.91 |
ENST00000542179.1 |
LDHA |
lactate dehydrogenase A |
chr15_+_89182156 | 0.90 |
ENST00000379224.5 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
chr20_-_60942326 | 0.88 |
ENST00000370677.3 ENST00000370692.3 |
LAMA5 |
laminin, alpha 5 |
chr2_-_233877912 | 0.87 |
ENST00000264051.3 |
NGEF |
neuronal guanine nucleotide exchange factor |
chr1_+_113217073 | 0.86 |
ENST00000369645.1 |
MOV10 |
Mov10, Moloney leukemia virus 10, homolog (mouse) |
chr1_+_113217043 | 0.85 |
ENST00000413052.2 |
MOV10 |
Mov10, Moloney leukemia virus 10, homolog (mouse) |
chr15_+_89181974 | 0.83 |
ENST00000306072.5 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
chr1_+_39456895 | 0.80 |
ENST00000432648.3 ENST00000446189.2 ENST00000372984.4 |
AKIRIN1 |
akirin 1 |
chr11_+_18417813 | 0.78 |
ENST00000540430.1 ENST00000379412.5 |
LDHA |
lactate dehydrogenase A |
chr20_-_60942361 | 0.77 |
ENST00000252999.3 |
LAMA5 |
laminin, alpha 5 |
chr16_-_51185149 | 0.77 |
ENST00000566102.1 ENST00000541611.1 |
SALL1 |
spalt-like transcription factor 1 |
chr16_-_19896150 | 0.74 |
ENST00000570142.1 |
GPRC5B |
G protein-coupled receptor, family C, group 5, member B |
chr22_-_37213045 | 0.72 |
ENST00000406910.2 ENST00000417718.2 |
PVALB |
parvalbumin |
chr11_-_71752571 | 0.71 |
ENST00000544238.1 |
NUMA1 |
nuclear mitotic apparatus protein 1 |
chr5_+_32531893 | 0.71 |
ENST00000512913.1 |
SUB1 |
SUB1 homolog (S. cerevisiae) |
chr22_-_30662828 | 0.66 |
ENST00000403463.1 ENST00000215781.2 |
OSM |
oncostatin M |
chr1_+_200993071 | 0.65 |
ENST00000446333.1 ENST00000458003.1 |
RP11-168O16.1 |
RP11-168O16.1 |
chr12_+_13349711 | 0.65 |
ENST00000538364.1 ENST00000396301.3 |
EMP1 |
epithelial membrane protein 1 |
chr1_+_113217309 | 0.63 |
ENST00000544796.1 ENST00000369644.1 |
MOV10 |
Mov10, Moloney leukemia virus 10, homolog (mouse) |
chr12_+_13349650 | 0.62 |
ENST00000256951.5 ENST00000431267.2 ENST00000542474.1 ENST00000544053.1 |
EMP1 |
epithelial membrane protein 1 |
chr8_+_61822605 | 0.62 |
ENST00000526936.1 |
AC022182.1 |
AC022182.1 |
chr16_-_46797149 | 0.62 |
ENST00000536476.1 |
MYLK3 |
myosin light chain kinase 3 |
chr9_-_98268883 | 0.60 |
ENST00000551630.1 ENST00000548420.1 |
PTCH1 |
patched 1 |
chrX_-_53310791 | 0.60 |
ENST00000375365.2 |
IQSEC2 |
IQ motif and Sec7 domain 2 |
chr2_+_27071292 | 0.59 |
ENST00000431402.1 ENST00000434719.1 |
DPYSL5 |
dihydropyrimidinase-like 5 |
chr6_+_123100620 | 0.58 |
ENST00000368444.3 |
FABP7 |
fatty acid binding protein 7, brain |
chr1_+_19967014 | 0.58 |
ENST00000428975.1 |
NBL1 |
neuroblastoma 1, DAN family BMP antagonist |
chrX_+_46937745 | 0.58 |
ENST00000397180.1 ENST00000457380.1 ENST00000352078.4 |
RGN |
regucalcin |
chr19_-_33716750 | 0.57 |
ENST00000253188.4 |
SLC7A10 |
solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 |
chr14_+_24867992 | 0.56 |
ENST00000382554.3 |
NYNRIN |
NYN domain and retroviral integrase containing |
chr19_-_41388657 | 0.56 |
ENST00000301146.4 ENST00000291764.3 |
CYP2A7 |
cytochrome P450, family 2, subfamily A, polypeptide 7 |
chr11_-_33913708 | 0.56 |
ENST00000257818.2 |
LMO2 |
LIM domain only 2 (rhombotin-like 1) |
chrX_-_102319092 | 0.55 |
ENST00000372728.3 |
BEX1 |
brain expressed, X-linked 1 |
chr8_-_141728444 | 0.55 |
ENST00000521562.1 |
PTK2 |
protein tyrosine kinase 2 |
chr8_-_80680078 | 0.54 |
ENST00000337919.5 ENST00000354724.3 |
HEY1 |
hes-related family bHLH transcription factor with YRPW motif 1 |
chr12_-_109797249 | 0.52 |
ENST00000538041.1 |
RP11-256L11.1 |
RP11-256L11.1 |
chr6_-_30043539 | 0.51 |
ENST00000376751.3 ENST00000244360.6 |
RNF39 |
ring finger protein 39 |
chr7_-_100076873 | 0.50 |
ENST00000300181.2 |
TSC22D4 |
TSC22 domain family, member 4 |
chr17_-_26903900 | 0.50 |
ENST00000395319.3 ENST00000581807.1 ENST00000584086.1 ENST00000395321.2 |
ALDOC |
aldolase C, fructose-bisphosphate |
chrX_+_102631248 | 0.48 |
ENST00000361298.4 ENST00000372645.3 ENST00000372635.1 |
NGFRAP1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr6_+_31950150 | 0.48 |
ENST00000537134.1 |
C4A |
complement component 4A (Rodgers blood group) |
chr9_-_132515302 | 0.48 |
ENST00000340607.4 |
PTGES |
prostaglandin E synthase |
chr8_+_102064237 | 0.47 |
ENST00000514926.1 |
RP11-302J23.1 |
RP11-302J23.1 |
chr1_-_41950342 | 0.47 |
ENST00000372587.4 |
EDN2 |
endothelin 2 |
chr20_+_61299155 | 0.47 |
ENST00000451793.1 |
SLCO4A1 |
solute carrier organic anion transporter family, member 4A1 |
chr19_-_12946215 | 0.46 |
ENST00000591512.1 ENST00000587549.1 ENST00000322912.5 |
RTBDN |
retbindin |
chr17_+_77030267 | 0.46 |
ENST00000581774.1 |
C1QTNF1 |
C1q and tumor necrosis factor related protein 1 |
chr8_+_94752349 | 0.45 |
ENST00000391680.1 |
RBM12B-AS1 |
RBM12B antisense RNA 1 |
chr2_+_220325977 | 0.45 |
ENST00000396686.1 ENST00000396689.2 |
SPEG |
SPEG complex locus |
chr2_-_217560248 | 0.45 |
ENST00000233813.4 |
IGFBP5 |
insulin-like growth factor binding protein 5 |
chr1_+_110453109 | 0.44 |
ENST00000525659.1 |
CSF1 |
colony stimulating factor 1 (macrophage) |
chrX_+_52240504 | 0.44 |
ENST00000399805.2 |
XAGE1B |
X antigen family, member 1B |
chr19_+_40195101 | 0.44 |
ENST00000360675.3 ENST00000601802.1 |
LGALS14 |
lectin, galactoside-binding, soluble, 14 |
chrX_-_52258669 | 0.44 |
ENST00000441417.1 |
XAGE1A |
X antigen family, member 1A |
chr1_-_109399682 | 0.43 |
ENST00000369995.3 ENST00000370001.3 |
AKNAD1 |
AKNA domain containing 1 |
chr18_+_33877654 | 0.43 |
ENST00000257209.4 ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3 |
formin homology 2 domain containing 3 |
chr17_-_39677971 | 0.43 |
ENST00000393976.2 |
KRT15 |
keratin 15 |
chr2_+_7017796 | 0.43 |
ENST00000382040.3 |
RSAD2 |
radical S-adenosyl methionine domain containing 2 |
chr19_-_1155118 | 0.43 |
ENST00000590998.1 |
SBNO2 |
strawberry notch homolog 2 (Drosophila) |
chr15_-_72523924 | 0.42 |
ENST00000566809.1 ENST00000567087.1 ENST00000569050.1 ENST00000568883.1 |
PKM |
pyruvate kinase, muscle |
chr16_+_30751953 | 0.41 |
ENST00000483578.1 |
RP11-2C24.4 |
RP11-2C24.4 |
chr15_+_45926919 | 0.41 |
ENST00000561735.1 ENST00000260324.7 |
SQRDL |
sulfide quinone reductase-like (yeast) |
chr5_-_115872142 | 0.41 |
ENST00000510263.1 |
SEMA6A |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chrX_+_52513455 | 0.40 |
ENST00000446098.1 |
XAGE1C |
X antigen family, member 1C |
chr5_+_150020240 | 0.40 |
ENST00000519664.1 |
SYNPO |
synaptopodin |
chr7_-_27187393 | 0.40 |
ENST00000222728.3 |
HOXA6 |
homeobox A6 |
chr11_-_62313090 | 0.40 |
ENST00000528508.1 ENST00000533365.1 |
AHNAK |
AHNAK nucleoprotein |
chr15_-_59665062 | 0.40 |
ENST00000288235.4 |
MYO1E |
myosin IE |
chr3_-_12200851 | 0.39 |
ENST00000287814.4 |
TIMP4 |
TIMP metallopeptidase inhibitor 4 |
chr1_+_44514040 | 0.39 |
ENST00000431800.1 ENST00000437643.1 |
RP5-1198O20.4 |
RP5-1198O20.4 |
chr11_-_128457446 | 0.39 |
ENST00000392668.4 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
chr15_+_90728145 | 0.39 |
ENST00000561085.1 ENST00000379122.3 ENST00000332496.6 |
SEMA4B |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
chr10_-_104597286 | 0.39 |
ENST00000369887.3 |
CYP17A1 |
cytochrome P450, family 17, subfamily A, polypeptide 1 |
chr17_-_76921459 | 0.39 |
ENST00000262768.7 |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
chr15_-_72523454 | 0.38 |
ENST00000565154.1 ENST00000565184.1 ENST00000389093.3 ENST00000449901.2 ENST00000335181.5 ENST00000319622.6 |
PKM |
pyruvate kinase, muscle |
chrX_-_52531609 | 0.38 |
ENST00000438079.1 |
XAGE1D |
X antigen family, member 1D |
chr19_-_35454953 | 0.38 |
ENST00000404801.1 |
ZNF792 |
zinc finger protein 792 |
chr17_+_7462103 | 0.38 |
ENST00000396545.4 |
TNFSF13 |
tumor necrosis factor (ligand) superfamily, member 13 |
chr19_+_50936142 | 0.38 |
ENST00000357701.5 |
MYBPC2 |
myosin binding protein C, fast type |
chr20_+_43343886 | 0.37 |
ENST00000190983.4 |
WISP2 |
WNT1 inducible signaling pathway protein 2 |
chr1_-_16539094 | 0.37 |
ENST00000270747.3 |
ARHGEF19 |
Rho guanine nucleotide exchange factor (GEF) 19 |
chr6_-_16761678 | 0.37 |
ENST00000244769.4 ENST00000436367.1 |
ATXN1 |
ataxin 1 |
chr11_-_65325430 | 0.37 |
ENST00000322147.4 |
LTBP3 |
latent transforming growth factor beta binding protein 3 |
chr1_-_229569834 | 0.36 |
ENST00000366684.3 ENST00000366683.2 |
ACTA1 |
actin, alpha 1, skeletal muscle |
chr17_+_7461849 | 0.36 |
ENST00000338784.4 |
TNFSF13 |
tumor necrosis factor (ligand) superfamily, member 13 |
chr20_+_43343517 | 0.36 |
ENST00000372865.4 |
WISP2 |
WNT1 inducible signaling pathway protein 2 |
chr8_+_22022653 | 0.36 |
ENST00000354870.5 ENST00000397816.3 ENST00000306349.8 |
BMP1 |
bone morphogenetic protein 1 |
chr7_-_100076765 | 0.36 |
ENST00000393991.1 |
TSC22D4 |
TSC22 domain family, member 4 |
chr20_+_43343476 | 0.34 |
ENST00000372868.2 |
WISP2 |
WNT1 inducible signaling pathway protein 2 |
chr12_+_66217911 | 0.34 |
ENST00000403681.2 |
HMGA2 |
high mobility group AT-hook 2 |
chrX_-_154376044 | 0.33 |
ENST00000362018.2 |
MTCP1 |
mature T-cell proliferation 1 |
chr10_+_124320156 | 0.33 |
ENST00000338354.3 ENST00000344338.3 ENST00000330163.4 ENST00000368909.3 ENST00000368955.3 ENST00000368956.2 |
DMBT1 |
deleted in malignant brain tumors 1 |
chr1_-_113247543 | 0.33 |
ENST00000414971.1 ENST00000534717.1 |
RHOC |
ras homolog family member C |
chrX_-_83757399 | 0.33 |
ENST00000373177.2 ENST00000297977.5 ENST00000506585.2 ENST00000449553.2 |
HDX |
highly divergent homeobox |
chr9_+_34646624 | 0.32 |
ENST00000450095.2 ENST00000556278.1 |
GALT GALT |
galactose-1-phosphate uridylyltransferase Uncharacterized protein |
chr5_-_111093081 | 0.32 |
ENST00000453526.2 ENST00000509427.1 |
NREP |
neuronal regeneration related protein |
chr8_-_145701718 | 0.32 |
ENST00000377317.4 |
FOXH1 |
forkhead box H1 |
chr15_-_40213080 | 0.32 |
ENST00000561100.1 |
GPR176 |
G protein-coupled receptor 176 |
chr7_-_7575477 | 0.32 |
ENST00000399429.3 |
COL28A1 |
collagen, type XXVIII, alpha 1 |
chr17_-_48474828 | 0.31 |
ENST00000576448.1 ENST00000225972.7 |
LRRC59 |
leucine rich repeat containing 59 |
chr20_+_33759854 | 0.31 |
ENST00000216968.4 |
PROCR |
protein C receptor, endothelial |
chr1_+_168250194 | 0.31 |
ENST00000367821.3 |
TBX19 |
T-box 19 |
chr17_+_19314505 | 0.31 |
ENST00000461366.1 |
RNF112 |
ring finger protein 112 |
chr2_+_10442993 | 0.31 |
ENST00000423674.1 ENST00000307845.3 |
HPCAL1 |
hippocalcin-like 1 |
chr2_+_233385173 | 0.31 |
ENST00000449534.2 |
PRSS56 |
protease, serine, 56 |
chr1_-_32169920 | 0.31 |
ENST00000373672.3 ENST00000373668.3 |
COL16A1 |
collagen, type XVI, alpha 1 |
chr1_-_44497118 | 0.30 |
ENST00000537678.1 ENST00000466926.1 |
SLC6A9 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
chr5_+_150020214 | 0.30 |
ENST00000307662.4 |
SYNPO |
synaptopodin |
chr1_-_32169761 | 0.30 |
ENST00000271069.6 |
COL16A1 |
collagen, type XVI, alpha 1 |
chr1_-_92949505 | 0.30 |
ENST00000370332.1 |
GFI1 |
growth factor independent 1 transcription repressor |
chr17_-_42992856 | 0.30 |
ENST00000588316.1 ENST00000435360.2 ENST00000586793.1 ENST00000588735.1 ENST00000588037.1 ENST00000592320.1 ENST00000253408.5 |
GFAP |
glial fibrillary acidic protein |
chr8_+_22022800 | 0.30 |
ENST00000397814.3 |
BMP1 |
bone morphogenetic protein 1 |
chr2_+_220325441 | 0.29 |
ENST00000396688.1 |
SPEG |
SPEG complex locus |
chr17_+_7461781 | 0.29 |
ENST00000349228.4 |
TNFSF13 |
tumor necrosis factor (ligand) superfamily, member 13 |
chr3_+_63953415 | 0.28 |
ENST00000484332.1 |
ATXN7 |
ataxin 7 |
chr22_-_24641027 | 0.28 |
ENST00000398292.3 ENST00000263112.7 ENST00000418439.2 ENST00000424217.1 ENST00000327365.4 |
GGT5 |
gamma-glutamyltransferase 5 |
chr6_+_123100853 | 0.28 |
ENST00000356535.4 |
FABP7 |
fatty acid binding protein 7, brain |
chr7_-_5463175 | 0.28 |
ENST00000399537.4 ENST00000430969.1 |
TNRC18 |
trinucleotide repeat containing 18 |
chr1_-_27816556 | 0.27 |
ENST00000536657.1 |
WASF2 |
WAS protein family, member 2 |
chr16_+_222846 | 0.27 |
ENST00000251595.6 ENST00000397806.1 |
HBA2 |
hemoglobin, alpha 2 |
chr5_+_52083730 | 0.26 |
ENST00000282588.6 ENST00000274311.2 |
ITGA1 PELO |
integrin, alpha 1 pelota homolog (Drosophila) |
chr7_+_128355439 | 0.26 |
ENST00000315184.5 |
FAM71F1 |
family with sequence similarity 71, member F1 |
chr9_+_34646651 | 0.26 |
ENST00000378842.3 |
GALT |
galactose-1-phosphate uridylyltransferase |
chr12_+_57522439 | 0.26 |
ENST00000338962.4 |
LRP1 |
low density lipoprotein receptor-related protein 1 |
chrX_+_102631844 | 0.25 |
ENST00000372634.1 ENST00000299872.7 |
NGFRAP1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr4_+_130014836 | 0.25 |
ENST00000502887.1 |
C4orf33 |
chromosome 4 open reading frame 33 |
chr19_+_45202421 | 0.25 |
ENST00000587331.1 |
CEACAM16 |
carcinoembryonic antigen-related cell adhesion molecule 16 |
chr17_+_72428218 | 0.25 |
ENST00000392628.2 |
GPRC5C |
G protein-coupled receptor, family C, group 5, member C |
chr11_-_111637083 | 0.25 |
ENST00000427203.2 ENST00000341980.6 ENST00000311129.5 ENST00000393055.2 ENST00000426998.2 ENST00000527614.1 |
PPP2R1B |
protein phosphatase 2, regulatory subunit A, beta |
chr1_-_32264250 | 0.25 |
ENST00000528579.1 |
SPOCD1 |
SPOC domain containing 1 |
chr11_-_10829851 | 0.24 |
ENST00000532082.1 |
EIF4G2 |
eukaryotic translation initiation factor 4 gamma, 2 |
chr19_+_4007644 | 0.24 |
ENST00000262971.2 |
PIAS4 |
protein inhibitor of activated STAT, 4 |
chr19_-_6737576 | 0.24 |
ENST00000601716.1 ENST00000264080.7 |
GPR108 |
G protein-coupled receptor 108 |
chr7_-_100065686 | 0.24 |
ENST00000423266.1 ENST00000456330.1 |
TSC22D4 |
TSC22 domain family, member 4 |
chr19_+_1491144 | 0.24 |
ENST00000233596.3 |
REEP6 |
receptor accessory protein 6 |
chr6_+_34204642 | 0.24 |
ENST00000347617.6 ENST00000401473.3 ENST00000311487.5 ENST00000447654.1 ENST00000395004.3 |
HMGA1 |
high mobility group AT-hook 1 |
chr6_+_150920999 | 0.23 |
ENST00000367328.1 ENST00000367326.1 |
PLEKHG1 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
chr19_+_16222439 | 0.23 |
ENST00000300935.3 |
RAB8A |
RAB8A, member RAS oncogene family |
chr5_-_111093340 | 0.22 |
ENST00000508870.1 |
NREP |
neuronal regeneration related protein |
chr22_+_50639408 | 0.22 |
ENST00000380903.2 |
SELO |
Selenoprotein O |
chr16_-_2264779 | 0.22 |
ENST00000333503.7 |
PGP |
phosphoglycolate phosphatase |
chr19_-_42927251 | 0.22 |
ENST00000597001.1 |
LIPE |
lipase, hormone-sensitive |
chr5_+_140855495 | 0.22 |
ENST00000308177.3 |
PCDHGC3 |
protocadherin gamma subfamily C, 3 |
chr11_+_61717279 | 0.21 |
ENST00000378043.4 |
BEST1 |
bestrophin 1 |
chr12_-_53228079 | 0.21 |
ENST00000330553.5 |
KRT79 |
keratin 79 |
chr14_+_85996507 | 0.21 |
ENST00000554746.1 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
chr7_-_81399438 | 0.21 |
ENST00000222390.5 |
HGF |
hepatocyte growth factor (hepapoietin A; scatter factor) |
chr6_+_31982539 | 0.21 |
ENST00000435363.2 ENST00000425700.2 |
C4B |
complement component 4B (Chido blood group) |
chr14_-_36645674 | 0.21 |
ENST00000556013.2 |
PTCSC3 |
papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding) |
chr16_+_57653625 | 0.21 |
ENST00000567553.1 ENST00000565314.1 |
GPR56 |
G protein-coupled receptor 56 |
chr1_-_242612726 | 0.21 |
ENST00000459864.1 |
PLD5 |
phospholipase D family, member 5 |
chr22_+_40390930 | 0.21 |
ENST00000333407.6 |
FAM83F |
family with sequence similarity 83, member F |
chrX_-_54522558 | 0.21 |
ENST00000375135.3 |
FGD1 |
FYVE, RhoGEF and PH domain containing 1 |
chr2_-_25475120 | 0.20 |
ENST00000380746.4 ENST00000402667.1 |
DNMT3A |
DNA (cytosine-5-)-methyltransferase 3 alpha |
chrX_-_154688276 | 0.20 |
ENST00000369445.2 |
F8A3 |
coagulation factor VIII-associated 3 |
chr9_+_102584128 | 0.20 |
ENST00000338488.4 ENST00000395097.2 |
NR4A3 |
nuclear receptor subfamily 4, group A, member 3 |
chr22_-_20368028 | 0.20 |
ENST00000404912.1 |
GGTLC3 |
gamma-glutamyltransferase light chain 3 |
chr6_+_31949801 | 0.20 |
ENST00000428956.2 ENST00000498271.1 |
C4A |
complement component 4A (Rodgers blood group) |
chr17_+_79369249 | 0.20 |
ENST00000574717.2 |
RP11-1055B8.6 |
Uncharacterized protein |
chr19_+_36606354 | 0.20 |
ENST00000589996.1 ENST00000591296.1 |
TBCB |
tubulin folding cofactor B |
chr17_-_41910505 | 0.20 |
ENST00000398389.4 |
MPP3 |
membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3) |
chr11_-_68611721 | 0.20 |
ENST00000561996.1 |
CPT1A |
carnitine palmitoyltransferase 1A (liver) |
chr20_+_9049742 | 0.19 |
ENST00000437503.1 |
PLCB4 |
phospholipase C, beta 4 |
chr16_-_8962853 | 0.19 |
ENST00000565287.1 ENST00000311052.5 |
CARHSP1 |
calcium regulated heat stable protein 1, 24kDa |
chr1_+_95975672 | 0.19 |
ENST00000440116.2 ENST00000456933.1 |
RP11-286B14.1 |
RP11-286B14.1 |
chr1_+_153747746 | 0.19 |
ENST00000368661.3 |
SLC27A3 |
solute carrier family 27 (fatty acid transporter), member 3 |
chr6_+_135502501 | 0.19 |
ENST00000527615.1 ENST00000420123.2 ENST00000525369.1 ENST00000528774.1 ENST00000534121.1 ENST00000534044.1 ENST00000533624.1 |
MYB |
v-myb avian myeloblastosis viral oncogene homolog |
chr4_+_110834033 | 0.19 |
ENST00000509793.1 ENST00000265171.5 |
EGF |
epidermal growth factor |
chr10_+_135160844 | 0.19 |
ENST00000423766.1 ENST00000458230.1 |
PRAP1 |
proline-rich acidic protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.5 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.5 | 2.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.5 | 1.5 | GO:2000366 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
0.4 | 1.1 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.3 | 3.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 1.2 | GO:0090678 | metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
0.2 | 2.3 | GO:1902363 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.2 | 0.6 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.2 | 4.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.6 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.2 | 0.5 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.2 | 0.5 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 0.6 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.2 | 0.5 | GO:1904204 | skeletal muscle hypertrophy(GO:0014734) regulation of skeletal muscle hypertrophy(GO:1904204) |
0.1 | 1.2 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.1 | 0.5 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.1 | 0.4 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.1 | 1.1 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.6 | GO:0010157 | response to chlorate(GO:0010157) |
0.1 | 0.6 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.1 | 0.7 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 1.3 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.1 | 0.4 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.1 | 0.3 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.1 | 1.2 | GO:0009615 | response to virus(GO:0009615) |
0.1 | 0.3 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.1 | 0.6 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.6 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.1 | 0.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.5 | GO:0021553 | olfactory nerve development(GO:0021553) olfactory bulb mitral cell layer development(GO:0061034) |
0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 0.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 2.4 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.8 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 1.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.4 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 0.8 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 1.7 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.9 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 1.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 2.1 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.1 | 0.2 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
0.1 | 0.3 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.1 | 0.2 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.1 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.3 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.1 | 0.5 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.9 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.3 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.4 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 0.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 1.8 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 1.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 3.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.1 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
0.0 | 0.4 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.2 | GO:0070846 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.0 | 0.2 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.0 | 1.2 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.6 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.7 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.0 | 0.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 1.7 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.0 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.0 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.0 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.1 | GO:0042704 | uterine wall breakdown(GO:0042704) |
0.0 | 0.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.3 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.0 | 1.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.3 | GO:0043010 | camera-type eye development(GO:0043010) |
0.0 | 0.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.7 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 0.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.0 | 0.2 | GO:2000504 | negative regulation of Fas signaling pathway(GO:1902045) positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.6 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
0.0 | 0.2 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.1 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.0 | 0.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) |
0.0 | 0.5 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.0 | 0.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.2 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.0 | 0.7 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.0 | 0.1 | GO:1902904 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.0 | 0.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.6 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.1 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.0 | 0.1 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.0 | 0.1 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.0 | 0.6 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.1 | GO:0060611 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.0 | 0.3 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.1 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.0 | 0.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:0048241 | epinephrine transport(GO:0048241) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.0 | 0.9 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.0 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0019474 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.0 | 0.2 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.0 | 1.2 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.0 | 0.1 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.0 | 0.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.1 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.2 | GO:0001711 | endodermal cell fate commitment(GO:0001711) positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.0 | GO:1904647 | response to rotenone(GO:1904647) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.7 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.3 | 1.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 0.7 | GO:0097444 | spine apparatus(GO:0097444) |
0.2 | 2.3 | GO:0055028 | cortical microtubule(GO:0055028) |
0.2 | 0.8 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.1 | 0.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 1.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.3 | GO:0036028 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.1 | 0.4 | GO:0030017 | sarcomere(GO:0030017) |
0.1 | 0.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.3 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.1 | 0.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.6 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.1 | GO:0042025 | host cell nucleus(GO:0042025) |
0.0 | 0.2 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.0 | 0.3 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.0 | 1.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 2.8 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 4.5 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.4 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.0 | 0.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 3.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.4 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.1 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.0 | 0.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 1.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 1.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.2 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.6 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.7 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.4 | 2.5 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 0.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 1.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 1.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 1.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 0.5 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.8 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.1 | 2.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.3 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
0.1 | 0.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 1.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 1.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.6 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 3.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.2 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.1 | 1.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.2 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.1 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.3 | GO:1902444 | riboflavin binding(GO:1902444) |
0.1 | 0.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.2 | GO:0015265 | urea channel activity(GO:0015265) |
0.0 | 0.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.7 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.2 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.1 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) norepinephrine transmembrane transporter activity(GO:0005333) acetate ester transmembrane transporter activity(GO:1901375) |
0.0 | 0.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
0.0 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 4.9 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 1.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.2 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.0 | 0.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 1.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.1 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 3.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.5 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 2.4 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.5 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 2.1 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 1.2 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 3.0 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 1.1 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
0.0 | 0.1 | GO:0050436 | microfibril binding(GO:0050436) |
0.0 | 0.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 2.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 4.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 1.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 1.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 1.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 4.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 1.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 3.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 1.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 2.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 5.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 2.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 1.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 1.7 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 0.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |